Pernod Ricard 1Q Sales EUR2.72B

Australia News News

Pernod Ricard 1Q Sales EUR2.72B
Australia Latest News,Australia Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 97%

Pernod Ricard reports strong sales, but sees the pace lessening in 2022

Pernod Ricard SA said Thursday that sales rose strongly in the first quarter of its fiscal year, with dynamic performance in both on-trade and off-trade and across geographies.

The group's largest geographic division, Asia/Rest of World, recorded the strongest organic increase of 23%, but the Americas and Europe also posted double-digit increases.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Kobalt Capital Sells Music Rights Including McCartney, Lorde For $1.1 BillionKobalt Capital Sells Music Rights Including McCartney, Lorde For $1.1 BillionKobalt Capital has sold its music publishing portfolio of 62,000 copyrights — including songs from Lorde and Paul McCartney — for roughly $1.1 billion
Read more »

Jamie Lynn Spears Is 'Blindsided' After Nonprofit Declines Proceeds from Her Memoir SalesJamie Lynn Spears Is 'Blindsided' After Nonprofit Declines Proceeds from Her Memoir Sales'We have made the decision to decline the offer of receiving proceeds from the book sales.'
Read more »

You Don't Have To Wait To Score These Insanely Early Black Friday DealsYou Don't Have To Wait To Score These Insanely Early Black Friday DealsIt's never to soon for a sale.
Read more »

'Nightmare On Elm Street' House For Sale Until Halloween'Nightmare On Elm Street' House For Sale Until HalloweenThe house from 'A Nightmare on Elm Street' is up for sale.
Read more »

J&J Covid vaccine adds $502 million to third-quarter salesJ&J Covid vaccine adds $502 million to third-quarter salesCNBC's 'Squawk Box' breaks down Johnson & Johnson's latest third-quarter earnings report.
Read more »

J&J bullish on 2021 profits, keeps vaccine sales outlook unchangedJ&J bullish on 2021 profits, keeps vaccine sales outlook unchangedJohnson & Johnson on Tuesday raised its annual adjusted profit forecast, but stuck to its COVID-19 vaccine sales target of $2.5 billion as it works through production challenges that have resulted in delays.
Read more »



Render Time: 2025-03-15 11:14:25